Spinocerebellar ataxia type 23 (SCA23): a review

被引:25
|
作者
Wu, Fan [1 ]
Wang, Xu [1 ]
Li, Xiaohan [1 ]
Teng, Huidi [1 ]
Tian, Tao [2 ]
Bai, Jing [1 ]
机构
[1] First Hosp Jilin Univ, Dept Neurol, Changchun 130021, Peoples R China
[2] First Hosp Jilin Univ, Dept Cardiol, Changchun 130021, Peoples R China
关键词
Spinocerebellar ataxia type 23; Prodynorphin; Clinical symptoms; Pathophysiological mechanisms; Epigenetics; Spinocerebellar ataxias; DOMINANT CEREBELLAR-ATAXIA; PRODYNORPHIN-DERIVED PEPTIDE; DYNORPHIN-A; HEREDITARY ATAXIAS; BIG DYNORPHIN; EPIGENETICS; MUTATIONS; MECHANISM; GENETICS; CURRENTS;
D O I
10.1007/s00415-020-10297-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinocerebellar ataxias (SCAs), formerly known as autosomal dominant cerebellar ataxias (ADCAs), are a group of hereditary heterogeneous neurodegenerative diseases. Gait, progressive ataxia, dysarthria, and eye movement disorder are common symptoms of spinocerebellar ataxias. Other symptoms include peripheral neuropathy, cognitive impairment, psychosis, and seizures. Patients may lose their lives due to out of coordinated respiration and/or swallowing. Neurological signs cover pyramidal or extrapyramidal signs, spasm, ophthalmoplegia, hyperactive deep tendon reflexes, and so on. Different subtypes of SCAs present various clinical features. Spinocerebellar ataxia type 23 (SCA23), one subtype of the SCA family, is characterized by mutant prodynorphin (PDYN) gene. Based on literatures, this review details a series of SCA23, to improve a whole understanding of clinicians and point out the potential research direction of this dysfunction, including a history, pathophysiological mechanism, diagnosis and differential diagnosis, epigenetics, penetrance and prevalence, genetic counseling, treatment and prognosis.
引用
收藏
页码:4630 / 4645
页数:16
相关论文
共 50 条
  • [21] Spinocerebellar ataxia type 31 (SCA31)
    Kinya Ishikawa
    Journal of Human Genetics, 2023, 68 : 153 - 156
  • [22] Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3
    Verbeek, DS
    van de Warrenburg, BP
    Wesseling, P
    Pearson, PL
    Kremer, HP
    Sinke, RJ
    BRAIN, 2004, 127 : 2551 - 2557
  • [23] Cerebellar developmental deficits underlie neurodegenerative disorder spinocerebellar ataxia type 23
    Smeets, Cleo J. L. M.
    Ma, Kai Yu
    Fisher, Simon E.
    Verbeek, Dineke S.
    BRAIN PATHOLOGY, 2021, 31 (02) : 239 - 252
  • [24] Clinical and molecular analyses on two Japanese families with spinocerebellar ataxia type 23
    Kondo, Y.
    Miyazaki, D.
    Nakamura, K.
    Sato, S.
    Ohara, S.
    Yamaguchi, T.
    Ishikawa, M.
    Wakui, K.
    Kosho, T.
    Fukushima, Y.
    Sekijima, Y.
    Yoshida, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 307 - 307
  • [25] Nonmotor symptoms in Spinocerebellar ataxia type 12 (SCA 12)
    Choudhury, S.
    Basu, P.
    Mondal, S.
    Banerjee, R.
    Ganguly, J.
    Tiwari, M.
    Kumar, H.
    MOVEMENT DISORDERS, 2024, 39 : S613 - S613
  • [26] Spinocerebellar ataxia type 11 (SCA11): An update
    Gong, Ziwei
    Lei, Lifang
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2023, 58 (02) : 2623 - 2640
  • [27] Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance
    Rüb, U
    Del Turco, D
    Del Tredici, K
    de Vos, RAI
    Brunt, ER
    Reifenberger, G
    Seifried, C
    Schultz, C
    Auburger, G
    Braak, H
    BRAIN, 2003, 126 : 2257 - 2272
  • [28] LINKAGE STUDIES IN SPINOCEREBELLAR ATAXIA (SCA)
    ZOGHBI, HY
    POLLACK, MS
    FERRELL, RE
    DAIGER, SP
    LYONS, LA
    BEAUDET, AL
    ANNALS OF NEUROLOGY, 1986, 20 (03) : 401 - 401
  • [29] LINKAGE STUDIES IN SPINOCEREBELLAR ATAXIA (SCA)
    ZOGHBI, HY
    POLLACK, MS
    CALLAWAY, C
    FERRELL, RE
    DAIGER, SP
    LYONS, LA
    BEAUDET, AL
    HUMAN IMMUNOLOGY, 1986, 17 (02) : 136 - 137
  • [30] Evolution of ataxia in risk persons for spinocerebellar ataxia (SCA)
    Jacobi, H.
    duMontcel, S. Tezenas
    Klockgether, T.
    MOVEMENT DISORDERS, 2019, 34 : S104 - S105